STAN S31 FETAL HEART MONITOR

FDA Premarket Approval P020001 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a change to the lcd panel model, power supply unit, and addition of an internal fan. The device is indicated for use as an adjunct to fetal heart rate monitoring to determine whether obstetrical intervention is warranted when there is increased risk of developing metabolic acidosis. The device is intended for use in patients with: 1) planned vaginal delivery; 2) >36 completed weeks gestation; 3) singleton fetus; 4) vertex presentation; and 5) ruptured amniotic membranes.

DeviceSTAN S31 FETAL HEART MONITOR
Generic NameAnalyzer, Data, Obstetric
ApplicantNEOVENTA MEDICAL AB
Date Received2007-08-13
Decision Date2007-09-26
PMAP020001
SupplementS002
Product CodeHEO 
Advisory CommitteeObstetrics/Gynecology
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address NEOVENTA MEDICAL AB norra Agatan 32 se-431 35 molndal 

Supplemental Filings

Supplement NumberDateSupplement Type
P020001Original Filing
S009 2011-09-21 Real-time Process
S008 2011-07-07 30-day Notice
S007 2009-07-23 Normal 180 Day Track
S006 2009-09-11 Real-time Process
S005 2008-02-04 Real-time Process
S004 2007-10-11 Normal 180 Day Track
S003
S002 2007-08-13 Real-time Process
S001 2007-06-04 30-day Notice

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.